INFARCT SIZE has been estimated from plasma creatine kinase (CK) time-activity curves with a simple model attributing serial changes in plasma CK activity to release from the heart and concomitant disappearance from the circulation.'" 4 However, several factors are not encompassed by this approach 1 -2 -*~9 including: (1) potential contributions of isoenzymes of CK with different disappearance rates to plasma CK activity after myocardial infarction; (2) potential variations of the true disappearance rate of CK within the same experimental animal or patient during the interval of study; (3) the relatively poor conformity of CK time-activity curves after intravenous injection to single-exponential fits; and (4) the possibility that CK, like many other proteins, is distributed in at least one extravascular compartment.
With the development of quantitative assays for CK isoenzymes, the first pitfall could be avoided by analyzing MB ('myocardial') CK time-activity curves rather than total CK curves in patients. 10 In dogs, since myocardium contains only a modest amount of MB (<2%) 10 and since plasma CK activity after infarction is attributable primarily to MM CK," errors introduced in enzymatic estimation of infarct size due to variance between disappearance rates of isoenzymes of CK are likely to be modest.
Effects of hemodynamic alterations simulating those associated with complicated myocardial infarction, 10 myocardial infarction itself, 12 and of selected pharmacological interventions on CK disappearance 13 have been evaluated experimentally. Although CK disappearance may be affected by these and other physiological disturbances, changes observed have been relatively small.
In studies in conscious dogs, the disappearance rate (k<i) of CK from the circulation, a parameter needed for estimates of infarct size, has been calculated from singleexponential fits to plasma CK values after intravenous injection of canine myocardial CK. 1 -2 In clinical studies, kd has been estimated from analysis of the terminal portions of time-activity curves after myocardial infarction 2 ' 4 because frequent intravenous injection of purified CK in patients is not practical. However, neither estimate of k,, may be ideal. The rate of disappearance of enzyme activity after myocardial infarction may differ substantially from disappearance of enzyme activity after intravenous injection of partially purified myocardial CK. Furthermore, the observed rate of decline of plasma CK after infarction may not necessarily be the same as the true disappearance rate of enzyme activity because of continued release of CK from the heart or resupply of the vascular compartment from an extravascular distribution space. 9 Accordingly, the present study was undertaken to compare disappearance of enzyme from the cirulation after intravenous injection and after myocardial infarction. Because results after intravenous injection differed substantially with CK extracted from myocardium compared to CK extracted from plasma, the two preparations were compared by cellulose acetate electrophoresis, 14 radioimmunoassay, 15 gel chromatography, 16 and assay of stability during incubation in vitro. Plasma time-activity curves after bolus injection of both types of preparation conformed more closely to double-than to single-exponential curves, suggesting that CK may be distributed in at least one extravascular pool, in keeping with evidence that after infarction, enzyme is distributed in lymph as well as blood. 17 ' 18 Results obtained with a two-compartment model utilizing parameters estimated from doubleexponential fits provide estimates of CK disappearance that would account for more CK released from the heart and appearing in the blood after infarction calculated from activity in plasma than that accounted for previously.
Methods

BIOCHEMICAL PROCEDURES
CK activity was assayed in tissue extracts and plasma samples spectrophotometrically. Canine myocardial CK was extracted and partially purified (at least 150-fold) by ethanol fractionation and batch adsorption with DEAE-Sephadex A-50 under conditions in which only MM CK is isolated, judging from electrophoresis of the final product on cellulose acetate. 19 The exclusive extraction of MM is not surprising in view of the small proportion (approximately 2%) of canine myocardial CK contributed by isoenzymes other than MM. 10 For experiments with CK obtained from plasma, enzyme was obtained from conscious donor dogs to avoid possible effects of anesthetic agents on circulating CK. Plasma CK was elevated by at least 10-fold in donor dogs as follows: After blood was anticoagulated with 0.005 M neutralized ethylene glycol bis (j3-aminoethyl ether)/V,A7-tetraacetic acid(EGTA), 95% ethanol was added dropwise to plasma at 0-4° (maintained for all preparative steps) to a final concentration of 50% and the mixture stirred slowly for 30 minutes and centrifuged at 2000 g for 15 minutes. Ethanol was added to a final concentration of 70% in the supernatant fraction, and this mixture was stirred for 30 minutes and centrifuged. The pellet, containing CK, was resuspended in 0.05 M Tris-HCl, pH 7.4, 0.001 M mercaptoethanol in a volume equal to the initial of plasma and centrifuged again. NaCl was added to the supernatant fraction to yield a concentration of 0.05 M prior to adsorption of the mixture for 40 minutes with DEAE-Sephadex A-50 (66 ml of gel-100 ml of initial plasma volume), previously swelled in 0.05 M Tris-HCl, pH 7.4, 0.05 M NaCI, and 1 ITIM mercaptoethanol. After filtration through Whatman no.l paper, the filtrate was dialyzed for 48 hours against 0.01 M glycine-NaOH, pH 9.0. Precipitate formed during the dialysis was removed by centrifugation at 12,000 g and the supernatant fraction which contained CK was freeze-dried. The final specific activity of the preparation exceeded 100 IU/mg protein.
For use in other experiments, myocardial CK was obtained from crude extracts of normal myocardium and from zones of infarction identified by gross inspection 10 hours after coronary occlusion. Myocardium was excised within 10 minutes after the dog was killed with an overdose of intravenous sodium pentobarbital, and the tissue was squeezed through a muscle press. This crude homogenate was diluted in normal saline prior to intravenous administration to recipient oogs. This type of extract was used to avoid possible effects of purification on kinetics of myocardial CK injected into the circulation. Potential contributions of myokinase to apparent CK activity in plasma were excluded by evaluating plasma samples both with and without creatine phosphate as substrate.
For comparison in vitro, purified myocardial CK and CK extracted from plasma were analyzed by cellulose acetate electrophoresis, 14 Sephadex gel chromatography (to obtain approximate values for molecular weight), 16 radioimmunoassay, 15 and stability at 37°, pH 7.4, in serum that had previously been heat-inactivated at 55°C for 30 minutes.
ANIMAL PREPARATIONS
All studies of time-activity curves were performed in conscious rather than anesthetized dogs because of the marked inhibitory effect of anesthesia on CK disappearance in vivo. 1 For studies of plasma CK time-activity curves after intravenous injection of myocardial CK or CK extracted from plasma of donor dogs, enzyme was injected through a jugular venous catheter. Blood samples were obtained every 2 minutes for 10 minutes, every 5 VOL. 41, No. 6, DECEMBER 1977 minutes for 20 minutes, every 20 minutes for 2 hours, and then every 30 minutes for 6-17 hours. Blood samples from the recipient dog were collected in 0.005 M neutralized EGTA and centrifuged at 2000 g for 10 minutes prior to addition of mercaptoethanol to the supernatant fraction in a final concentration of 0.005 M, stored at 0-4°C, and assayed within 24 hours.
For studies of plasma CK time-activity curves after myocardial infarction, an exteriorized snare was placed around the left anterior descending coronary artery 1 week before each study in dogs anesthetized with sodium thiamylal, 10 mg/kg, and 0.05% fluothane. After plasma CK had returned to normal after surgery, coronary occlusion was produced in each conscious dog and plasma samples were obtained serially via an indwelling jugular venous cannula.
ANALYSIS OF RESULTS WITH A TWO-COMPARTMENT MODEL
Despite the convenience of evaluating plasma CK timeactivity curves with a one-compartment model, the behavior of several proteins, including CK, may be better described with multiple compartmental models, since the proteins may be distributed in extravascular as well as vascular pools. 9 -2021 In the present study, we compared fits with single and double exponentials. The doubleexponential function was used to obtain parameters for a two-compartment model ( Fig. I) 9 assuming distribution of CK in an extravascular compartment with first order transfer rates between blood and extravascular compartments and a first order elimination rate from blood.
FIGURE 1 Diagrammatic illustration of the two-compartment model: g(t) is any input function; E v (t) is enzyme activity in the vascular pool; E e (t) is enzyme activity in the extravascular pool;
\CT and X^f are exchange rates from vascular to extravascular and from extravascular to vascular pools; and X,, is the true disappearance rate of creatine kinase (CK) from the blood pool. As indicated in the text, X, is not the same as the observed slope of the plasma CK time-activity curve which is influenced not only by disappearance but also by resupply of the vascular pool from an extravascular compartment. Although CK activity may be eliminated from the extravascular pool, we have assumed that elimination occurs from blood only for two reasons: (1) disappearance of activity in lymph in vitro is very slow compared to disappearance from blood in vivo and (2) the assumption of elimination from both pools results in nonunique estimates for the two elimination rales.
With this model, the amount of CK present in the vascular and extravascular compartments as a function of time can be described by the following system of differential equations in which g(t) is any input function:
The solution to this system for the vascular pool under conditions in which CK is administered by bolus intravenous injection and g(t) is the function accounting for maintenance of normal plasma CK activity is of the form:
where C is the normal plasma CK level and the variables A, B, a, and /3 are functions of the rate constants and the initial conditions, i.e., the amount of CK present in the compartments at time zero. The four parameters of the solution can be obtained experimentally from doubleexponential fits to the plasma CK time-activity curves following bolus injections. From these fits, the rate constants can then be calculated from the following formulas:
To compare behavior of CK extracted from heart muscle and CK extracted from plasma of dogs with experimentally induced myocardial infarction, parameters in this model can be obtained from best-fit double-exponential curves after intravenous injection of each preparation.
The two-compartment model provides an estimate of the disappearance rate of CK from the circulation that is substantially greater than the observed rate of decline of activity in serial samples. This is because the model takes into account continuing supply of the vascular pool with enzyme from the extravascular compartment. Since enzymatic estimates of infarct size depend on the true disappearance rate as one parameter, the two-compartment model would account for more CK released from the heart based on calculations with a given plasma curve than the one-compartment model.
Results
CHARACTERIZATION OF CK DISAPPEARANCE WITH A TWO-COMPARTMENT MODEL
In our initial approach to enzymatic estimation of infarct size in experimental dogs,' we estimated kj from single-exponential fits to plasma CK values obtained after intravenous injection of partially purified canine myocardial CK. However, CK values during the first hour after infarction conformed poorly to a single exponential, and the approach utilized was recognized to be an oversimplification.
As can be seen in Figure 2 , the plasma CK time-activity curve after intravenous injection of purified myocardial CK conforms much more closely to a double-exponential than to a single-exponential fit. Results from six experiments are summarized in Table 1 . As can be seen, the overall standard deviation of the fit curves from the data are only 42% as large on the average with double-exponential compared to single-exponential fits.
As shown in Table 2 , values for the parameter X v , the true disappearance rate of CK, differ substantially from the values of the slope of the observed plasma CK timeactivity curve because resupply of the vascular pool from an extravascular compartment is taken into account by the model.
PLASMA CK TIME-ACTIVITY CURVES AFTER MYOCARDIAL INFARCTION
Construction of the left anterior descending coronary artery in a conscious dog results in a plasma CK timeactivity curve that peaks typically within 7-14 hours and declines slowly generally reaching a value of 10% of peak or less within 30 hours. Results in Table 3 were obtained t Expressed as percentage of plasma volume. The ratio of the extravascular space to plasma volume is obtained directly from the steady state solution to the differential equations in the text.
t In the one-compartment model, the only estimate of k that can be made is the slope of the semilog time-activity plot, with values corrected for background. by analyzing the declining portion of such curves from 18 conscious dogs subjected to coronary occlusion that survived for at least 24 hours. The estimate of the rate of disappearance was obtained from the slope of the best-fit straight line (least squares method) from a plot of In CK vs. time. The correlation coefficient of the fit in each case exceeded 0.91. In the fitting procedure, the initial value selected was 80% of peak CK and the last value used was the last value obtained or the first value with activity <100 mlU/ml. As can be seen in Table 3 , the average rate of decline of CK activity after myocardial infarction is substantially less than 0.005 min~!, the average rate of decline, calculated in the same fashion, after bolus injection of partially purified myocardial CK ( Table 2) . As can be seen in Figure 3 , in experiments in the same dog, the disparity between the slope of the curve after myocardial infarction and the rate of decline of plasma CK activity after bolus injection is striking.
PLASMA CK TIME-ACTIVITY CURVES AFTER INTRAVENOUS INJECTION OF ENZYME IN CRUDE EXTRACTS OF MYOCARDIUM OR CK HARVESTED FROM DONOR DOG PLASMA
Because the disparity between decline of CK after infarction and decline after injection of purified myocardial CK could have been due to alterations in CK associated with purification, additional experiments were performed with CK in crude extracts prepared from normal myocardium and zones of infarction. As can be seen in Figure 4 , the rate of decline of plasma CK activity after bolus injection of a crude extract of normal myocardium was similar to that after bolus injection of purified myocardial CK in the same dog studied 1 week later and substantially more rapid than the average rate of decline calculated from descending limbs of plasma CK timeactivity curves after myocardial infarction in 18 other dogs (Table 3) . Similar results with an average k,, after injection of 0.0082 were obtained in five analogous experiments with injection and infarction in the same dog. In two of these experiments, extracts were prepared from zones of infarction rather than from normal myocardium. These results suggest that purification of myocardial CK does not account for the difference in disappearance after intravenous injection compared to the rate seen after infarction.
On the other hand, release of CK into the plasma from ischemic myocardium in vivo may alter the molecule such that slower disappearance is observed. To evaluate this possibility, we harvested CK in plasma from donor dogs subjected to myocardial infarction and injected the plasma into recipients. To obviate possible effects of anesthesia in the donor plasma, infarction was produced in conscious dogs that then were bled when plasma CK activity was markedly elevated. Five hundred to 1000 IU of CK concentrated from plasma in a volume of 10 ml (n = 4) or in larger volumes were administered to recipient dogs, after which plasma CK time-activity curves were analyzed. Ten-milliliter volumes were utilized to avoid effects of marked expansion of vascular volume on results. In another experiment, an injectate of larger volume (114 ml containing 1000 IU of CK) was used to avoid possible effects of concentration of CK in the injectate on the kinetics of CK in the circulation of the recipient. Preparations of CK extract were used within 12 hours after storage at 0-4°C. The average rate of decline of plasma CK activity in all four experiments with 10-ml injectates, calculated from the slope of the best-fit line of the plot of In CK vs. time, was 0.004 ± 0.002 (SD) min"', less then 50% the rate of decline of activity after bolus injections of purified myocardial CK in the same dog in each case. Slow disappearance (<50% of that seen after injections of myocardial CK) was seen also in the experiment with the 114-ml injectate. These results suggest that native CK released into the circulation and harvested from plasma behaves differently from CK prepared from myocardium.
THE SHAPE OF DISAPPEARANCE CURVES OF CK HARVESTED FROM PLASMA
As can be seen in Figure 5 , disappearance curves of CK extracted from plasma and CK extracted from myocardium injected intravenously in the same recipient dog 1 week later exhibit similar shapes, although the rate of disappearance is substantially less with CK extracted from plasma. Data after both injections are fit better by a twoexponential, compared to a single-exponential curve. In each of two other dogs, similar results were obtained but the injection of myocardial CK was performed first. Estimates of the true disappearance rate (\ v ) of CK harvested from plasma and injected intravenously obtained with the two-compartment model were 44% less than the value for the same parameter after intravenous injection of purified myocardial CK in these three dogs.
POTENTIAL CONTRIBUTORS TO THE OBSERVED DIFFERENCES IN DISAPPEARANCE RATE Biochemical Differences
Disappearance rates of several purified proteins injected intravenously differ markedly in comparison to the physiological turnover rates of the corresponding proteins. 22 ' 23 In general, these differences cannot be attributed to changes in primary structure, but appear to reflect subtle alterations in conformation of prosthetic groups. 20 In tne present study, results of several experiments in vitro indicate that CK extracted from plasma remained quite similar to CK extracted from myocardium. Addition of EGTA (added to plasma) to myocardial CK preparations did not change results. The ratio of enzyme activity to displacement binding of plasma myocardial CK in a recently developed radioimmunoassay system was virtually identical with an average of 57% and 53% with 0.16 IU/liter; and 83% and 82% with 1.6 IU/liter with purified compared to native enzyme (n = four experiments with each). Electrophoretic mobility of both preparations was the same on cellulose acetate at pH 8.8. The elution profile of CK enzyme activity on G-150 Sephadex columns was the same when preparations extracted from plasma were compared to those extracted from myocardium ( Fig. 6) , with approximate molecular weight of CK in the two preparations of 85,000 daltons.
We previously have shown that CK activity declines more slowly when enzyme is incubated in plasma or serum in vitro compared to the rate of decline in vivo after bolus injection intravenously or after experimentally induced myocardial infarction. 24 When CK extracted from plasma was incubated in heat-inactivated serum in vitro, the rate of decline of activity (10% in 2 hours) was comparable to that seen with CK extracted from myocardium incubated under the same conditions. Thus, the striking disparity between rates of disappearance in vivo of CK extracted from plasma compared to CK extracted from myocardium is not accompanied by gross changes in binding to antibody, charge and migration in an electrophoretic field, molecular weight, or lability in vitro.
Slow Filling of an Exlravascular Compartment
CK disappearance after myocardial infarction might be slowed by resupply of the vascular pool form an extravascular compartment that fills slowly. To simulate conditions that might be required for filling of such a compartment, CK was injected repeatedly intravenously in the same normal conscious dog prior to evaluation of the plasma CK time-activity curve. Purified myocardial CK (>110 IU/mg) was injected in doses of 120 IU/kg body weight every hour for 10 hours with persistent and marked elevations of plasma CK resulting throughout the interval. CK disappearance was evaluated beginning at the time when plasma CK activity was maximum after the last injection (1433 mlU/ml) and continuing for 7 hours and until CK activity had returned to <150 mlU/ml. The rate of disappearance observed under these conditions was 0.006 min" 1 (based on a single-exponential fit), substan-VOL. 41, No. 6, DECEMBER 1977 tially greater than 0.002 min ', the average rate after myocardial infarction (Table 3) .
POTENTIAL CONTRIBUTIONS OF CK RELEASED LATE AFTER MYOCARDIAL INFARCTION TO PLASMA CK TIME-ACTIVITY CURVES
One possible reason for the slower rate of decline of plasma CK activity after myocardial infarction compared to that seen after intravenous injection of enzyme is continued release of CK from ischemic myocardium relatively late during the evolution of infarction. Since canine myocardium contains CK activity of approximately 2000 IU/g, 25 and since peak plasma CK activity in a 20-kg dog with myocardial infarction is of the order of 1200 mlU/ ml, continued release from even a small region of myocardium would distort the descending limb of the curve substantially. For example, continuing release after occurrence of peak plasma CK from only 3 g of myocardium would reduce the slope of the descending limb of the plasma CK time-activity curve by approximately 50% if the true disappearance rate were 0.005 min" 1 .
Administration of zymosan intravenously in conscious dogs reduces the decline in plasma CK activity after intravenous injection of partially purified myocardial CK. 10 In the present study, to detect continuing release when plasma CK activity was declining after myocardial infarction, we injected zymosan intravenously (10 mg/kg) at selected intervals after the occurrence of peak plasma CK activity. As can be seen in Figure 7 , administration of 10,000 • 1,000 -40 0
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FIGURE 7
Effects of zymosan injected intravenously on evolving plasma CK time-activity curves after myocardial infarction in conscious dogs. As can be seen, when zymosan was injected 8 hours after CK activity had peaked, elimination of CK from blood was inhibited but no overall rise occurred (A). In contrast, when zymosan was administered earlier after peak CK, in this case within 4 hours, the decline of CK activity was not only inhibited but accompanied by an increase in plasma CK (B). These observations suggest that continuing release of CK from the heart was occurring at the lime when zymosan was administered soon after peak. Since zymosan inhibited CK disappearance, the continued release would result in an overall increase in plasma CK activity accounting for the secondary peak observed.
zymosan more than 8 hours after peak CK activity had occurred slowed disappearance. When zymosan was administered earlier after peak plasma CK, not only was disappearance slowed, but in addition, plasma CK increased. Similar results were obtained in four other experiments, two each with zymosan given within 4 hours of peak or more than 8 hours after peak CK (data not shown). This appears likely to have been due to continuing release from the heart for a considerable interval after the occurrence of peak CK, with the rate of release exceeding the rate of disappearance persisting in the face of zymosan. These results suggest that continuing release of CK from the heart is one factor contributing to the relatively slow decline of plasma CK after infarction compared to CK disappearance after intravenous injection of myocardial CK or CK harvested from plasma of donor dogs.
Discussion
This study indicates the following: (1) plasma CK timeactivity curves after injection of myocardial or plasma CK are fit by double-exponential better than by single-exponential curves; (2) estimates of the true CK disappearance rate based on a two-compartment model (with parameters obtained from double-exponential fits) are substantially higher than observed elimination rates; (3) disappearance of CK after infarction is substantially slower than disappearance after injection of either myocardial or plasma CK; (4) the relatively slow disappearance after infarction does not appear to reflect a different distribution volume compared to the volume after injection, judging from the rapid CK disappearance seen after repeated intravenous injections; and (5) both physical differences between extracted myocardial CK and containued release from the ischemic heart appear to contribute to the relatively slow disappearance seen after infarction.
Regardless of whether extracts from myocardium were prepared with ethanol fraction, ammonium sulfate precipitation, and batch adsorption to DEAE-Sephadex A-50, or whether they were prepared by simply squeezing intracellular fluid from broken cell preparations with a muscle press, disappearance rates of enzyme in the extracts were rapid after bolus intravenous injection. On the other hand, purification of CK in plasma with similar chemical manipulations did not lead to rapid disappearance after bolus injection. Thus, physical differences appear to be a contributing factor. Continued release appears to contribute to the relatively slow disappearance after infarction as well, judging from the experiments with zymosan.
Qualitatively, disappearance appears to be similar for myocardial or plasma CK with curves of both fit more closely by double-exponential than single-exponential curves. The good agreement between observed and fit values supports the two-compartment model described and suggests that the true CK disappearance rate is substantially higher than the observed elimination rate because of resupply of the vascular pool from the extravascular space.
IMPLICATIONS REGARDING ENZYMATIC ESTIMATION OF INFARCT SIZE
With the one-compartment model utilized previously, 1 " 5 calculations of infarct size depend on the value used for k<j in an interesting fashion. Thus, infarct size (IS) = (K) (BW) (CK R ) (1) where BW is body weight, CK R is cumulative CK released by the heart, and K is a proportionality constant. CK release from the heart is calculated from observed serial plasma CK values as
where E(t) equals plasma CK activity at time t, and CK B is cumulative CK released by the heart up to time T. 5 The proportionality constant (K) relates CK R to grams of myocardium undergoing infarction and can be expressed as
where DV is the distribution volume of CK per unit body weight, CK N and CK, are activity in homogeneous regions of normal myocardium and infarcts, and P is the proportion of CK rleased into blood compared to CK depleted from the heart assayed directly by measurements in myocardial extracts. This value is determined experimentally by assuming a value for k^ and measuring CK loss from the heart in animals with infarction. 1 If the estimate of k<| used in such studies deviates from the true CK disappearance rate, the resulting estimate of P will deviate proportionally. Since kj appears in the numerator and P appears in the denominator of Equation 3, errors in the estimate of k<j and P will be offsetting. These considerations apply as long as the same approach is used to estimate kj in experiments in which infarct size is estimated by analysis of plasma CK time-activity curves and in experiments used to obtain estimates of P.
When average values for kj are used in enzymatic estimates of infarct size, the error in each individual case will depend on the variance of the true CK disappearance rate among individuals. In other words, the extent to which kd in an individual differs from the average value of k<j used in obtaining an estimate of K will affect estimated infarct size since kj influences the estimate of CK R (Equation 2 ). With the data available (Table 2) , only modest differences are evident in the variances between k^ calculated from a one-compartment model and the estimate of the true disappearance rate calculated from the two-compartment model. However, the twocompartment model accounts for recovery of substantially more CK release from the heart, as shown in Table 4 . If estimates of the true CK disappearance rate were obtained under the same experimental conditions and the average value from the two models applied to estimates of infarct size, relative estimates of infarct size would not be affected substantially. However, the proportion of CK lost from the heart accounted for by analysis of plasma CK time- 13 ,700 3,070 32,130
The \ v and k values were obtained by analyzing the data obtained in six studies of plasma CK time-activity curves after intravenous injection of purified myocardial CK ( Table 2) . These parameters were used to calculate CK released from plasma CK time-activity curves in three conscious dogs subjected to coronary occlusion. activity curves after infarction is almost 2-fold greater when the parameter is obtained from the two-compartment rather than the one-compartment model.
Unfortunately, plasma CK curves after myocardial infarction cannot be used directly to obtain parameters of the two-compartment model. This is because of probable contributions of continuing release of CK from the heart, and also because initial conditions (i.e., the amount of CK present in both compartments at the onset of the interval used for analysis) cannot be characterized directly. On the other hand, improved average estimates of k,), obtained from time-activity curves after intravenous injection of CK analyzed with a two-compartment model, can be utilized to obtain enzymatic estimates of infarct size that account for recovery of substantially more CK released from the heart than that accounted for in previous studies.
Effects of various autonomic drugs on the lamb fetal circulation have been extensively investigated. 4 -6 Among the fetal blood vessels, the ductus arteriosus is unique for being highly responsive to acetylcholine (ACh). However, a systematic investigation of the fetal vascular segments from different circulatory regions is yet to be undertaken.
The purpose of the present work was to determine whether fetal blood vessels are heterogeneous in their affinity for or maximal response to neurohumoral agents and, if so, whether such heterogeneity changes with gestational development.
Methods
Twenty-three ewes with dated pregnancies were used. Following spinal anesthesia with tetracaine, the fetus was delivered rapidly by cesarian section. The fetal head was covered immediately with a saline-filled rubber glove to prevent breathing. Under local anesthesia with lidocaine,
